Boston Scientific Analysts Boost Their Forecasts Following Upbeat Results
1. BSX reported Q1 2025 revenues of $4.66 billion, exceeding estimates. 2. Adjusted EPS was 75 cents, over the expected 67 cents. 3. The company anticipates 15%-17% revenue growth for 2025. 4. Analysts raised their price targets for BSX stock post-earnings. 5. BSX shares increased by 2.4% to $101.24 after earnings report.